Leukemia Research
Volume 26, Issue 11 , Pages 997-1005 , November 2002

Increased circulating normal and BCR-ABL+Ve progenitor numbers in Philadelphia chromosome-positive acute myeloid leukaemia

  • Paul Baines

      Affiliations

    • Haematology Department, University Hospital of Wales, Cardiff CF14 4XW, UK
    • Corresponding Author InformationCorresponding author. Tel.: +44-2920-743486; fax: +44-2920-744655.
    • ,
  • Steve Austin

      Affiliations

    • Haematology Department, University Hospital of Wales, Cardiff CF14 4XW, UK
    • ,
  • Janet Fisher

      Affiliations

    • Haematology Department, University Hospital of Wales, Cardiff CF14 4XW, UK
    • ,
  • Eleri Owen-Jones

      Affiliations

    • Haematology Department, University Hospital of Wales, Cardiff CF14 4XW, UK
    • ,
  • Lisa Lee-Jones

      Affiliations

    • Institute of Medical Genetics, Cardiff, UK
    • ,
  • Duncan Throp

      Affiliations

    • Haematology Department, University Hospital of Wales, Cardiff CF14 4XW, UK
    • ,
  • Mark Mckinley

      Affiliations

    • Haematology Department, University Hospital of Wales, Cardiff CF14 4XW, UK
    • ,
  • Terry Hoy

      Affiliations

    • University of Wales College of Medicine, Cardiff, UK
    • ,
  • Ken Mills

      Affiliations

    • University of Wales College of Medicine, Cardiff, UK
    • ,
  • Peter W Thompson

      Affiliations

    • Institute of Medical Genetics, Cardiff, UK
    • ,
  • Alan K Burnett

      Affiliations

    • Haematology Department, University Hospital of Wales, Cardiff CF14 4XW, UK

Received 16 October 2001 ,Accepted 9 February 2002.

References 

  1. Fialkow PJ, Singer JW, Raskind WH, Adamson JW, Jacobsen RJ, Bernstein RJ, et al.  Clonal development, stem cell differentiation and clinical remissions in acute nonlymphocytic leukemia. New Engl. Med. 1987;317:468
  2. Bernstein ID, Singer JW, Smith FO, Andrews RG, Flowers DA, Petersens J, et al.  Differences in the frequency of normal and clonal precursors of colony-forming cells in chronic myelogenous leukemia and acute myelogenous leukemia. Blood. 1992;79:1811
  3. Turhan AG, Lemoine FM, Debert C, Bonnet ML, Baillou C, Picard F, et al.  Highly purified primitive haematopoietic stem cells are PML-RAR negative and generate nonclonal progenitors in acute promyelocytic leukemia. Blood. 1995;85:2154
  4. Raymakers R, Wittebol S, Pennings A, Linders E, Poddighe P, De Witte T. Residual normal, highly proliferative progenitors can be isolated from the CD34+/CD33− fraction of AML with a more differentiated phenotype (CD33+). Leukemia. 1995;9:450
  5. Miyamoto T, Nagafuji K, Akashi K, Harada M, Kyo T, Akashi T, et al.  Persistence of multipotent progenitors expressing AML1/ETO transcripts in long-term remission patients with t(8;21) acute myelogenous leukemia. Blood. 1996;87:4789
  6. Greaves MF. Stem cell origins of leukemia and curability. Br. J. Cancer. 1993;67:413
  7. Moore MAS, Spitzer G, Williams N, Metcalf D, Buckley J. Agar culture studies in 127 cases of untreated acute leukemia: the prognostic value of reclassification of leukemia according to in vitro growth characteristics. Blood. 1974;44:1
  8. Beran M, Reizenstein P, Uden A-M. Response to treatment in acute non-lymphatic leukaemia: prognostic value of colony-forming and colony-stimulating capacities of bone marrow and blood cells compared to other parameters. Br. J. Haematol. 1980;44:39
  9. Kitano K, Sato Y, Suda T, Miura Y. Difference of cell lineage expression of haematopoietic progenitor cells in Philadelphia-positive acute lymphoblastic leukaemia and chronic myelogenous leukaemia. Br. J. Haematol. 1988;70:21
  10. Jinnai I. In vitro growth response to G-CSF and GM-CSF by bone marrow cells of patients with acute myeloid leukemia. Leuk. Res. 1990;14:227
  11. Ailles LE, Gerhard B, Hogge DE. Detection and characterization of primitive malignant and normal progenitors in patients with acute myelogenous leukemia using long-term coculture with supportive feeder layers and cytokines. Blood. 1997;90:2555
  12. Clarkson BD, Strife A, Wisniewski D, Lambek C, Carpino N. New understanding of the pathogenesis of CML: a prototype of early neoplasia. Leukemia. 1997;11:1404
  13. Heim S, Mitelman F. Chronic myeloid leukemia. In: Cancer cytogenetics. 2nd ed. NY: Wiley, 1995. p. 33 (chapter 4).
  14. Hermans A, Heisterkamp N, von Lindern M, van Baal S, Meijer D, van der Plas D, et al.  Unique fusion of BCR and C-ABL genes in Philadelphia chromosome-positive acute lymphoblastic leukaemia. Cell. 1987;51:33
  15. Schenk TM, Keyhani A, Bottcher S, Kliche K-O, Goodacre A, Guo J-Q, et al.  Multilineage involvement of Philadelphia chromosome-positive acute lymphoblastic leukemia. Leukemia. 1998;12:666
  16. Kurzrock R, Shtalrid M, Romero R, Kloetzer WS, Talpaz M, Trujillo JM, et al.  A novel c-abl protein product in Philadelphia-positive acute lymphoblastic leukaemia. Nature. 1987;325:631
  17. Clark SS, McLaughlin J, Crist WM, Champlin R, Witte ON. Unique forms of the abl tyrosine kinase distinguish Ph+ CML from Ph+ ALL. Science. 1987;235:85
  18. Chan LC, Karhi KK, Rayter SI, Heisterkamp N, Eridani S, Powles R, et al.  A novel abl protein expressed in Philadelphia chromosome-positive acute lymphoblastic leukemia. Nature. 1987;325:635
  19. Voncken JW, Griffiths S, Greaves MF, Pattengale PK, Heisterkamp N, Groffen J. Restricted oncogenicity of BCR-ABL p190 in transgenic mice. Cancer Res. 1992;52:4534
  20. Voncken JW, Kaartinen V, Pattengale PK, Germeraad WTV, Groffen J, Heisterkamp N. BCR-ABL p210 and p190 cause distinct leukemia in transgenic mice. Blood. 1995;86:4603
  21. Griffiths SD, Healy LE, Ford AM, Bennet CA, Voncken JW, Heisterkamp N, et al.  Clonal characteristics of acute lymphoblastic cells derived from BCR-ABL p190 transgenic mice. Oncogene. 1992;7:1391
  22. Castellanos A, Pintado B, Weruga E, Arevalo R, Lopez A, Orfao A, et al.  A BCR-ABL (p190) fusion gene made by homologous recombination causes B-cell acute lymphoblastic leukemias in chimeric mice with independence of the endogenous bcr product. Blood. 1997;90:2168
  23. Li S, Ilaria RL, Million RP, Daley G, Van Etten RA. The P190, P210 and P230 forms of the BCR/ABL oncogene induce a similar chronic myeloid leukemia-like syndrome in mice but have different lymphoid leukemogenic activity. J. Exp. Med. 1999;189:1399
  24. Kurzrock R, Shtalrid M, Talpaz M, Kloetzer WS, Gutterman JU. Expression of C-ABL in Philadelphia-positive acute myelogenous leukemia. Blood. 1987;70:1584
  25. Kantarjian HM, Talpaz M, Dhingra K, Estey E, Keating MJ, Ku S, et al.  Significance of the p210 versus the p190 molecular abnormalities in adults with Philadelphia chromosome-positive acute leukemia. Blood. 1991;78:2411
  26. Selleri L, Von Lindren M, Hermans A, Meijer D, Torelli G, Grosveld G. Chronic myeloid leukemia may be associated with several BCR-ABL transcripts including the acute lymphoid leukemia-type 7 kb transcript. Blood. 1990;75:1146
  27. Kuniedo Y, Okabe M, Kurosawa M, Itaya T, Kakinuma M, Miyazaki T. Chronic myeloid leukemia presenting ALL-type bcr/abl transcript. Ann. Hematol. 1994;69:189
  28. Kirk JA, Radich J, Edmands S, Lee A, Van Devanter DR, Reems JA, et al.  Unusual expression of mRNA typical of Philadelphia positive acute lymphoblastic leukemia detected in chronic myeloid leukemia. Am. J. Hematol. 1996;52:129
  29. Saglio G, Pane F, Gottardi E, Frigeri F, Buonaiuto MR, Guerrasio A, et al.  Consistent amounts of acute leukemia-associated p190BCR-ABL transcripts are expressed by chronic myelogenous leukemia patients at diagnosis. Blood. 1996;87:1075
  30. Lichty BD, Keating A, Callum J, Yee K, Croxford R, Corpus G, et al.  Expression of p210 and p190 BCR-ABL due to alternative splicing in chronic myelogenous leukemia. Br. J. Haematol. 1998;103:711
  31. Dhingra K, Talpaz M, Kantarjian H, Ku S, Rothberg J, Gutterman JU, et al.  Appearance of acute leukemia-associated P190 (BCR-ABL) in chronic myelogenous leukemia may correlate with disease progression. Leukemia. 1991;5:191
  32. Drouet X, Douay L, Giarratana MC, Baillou C, Gorin NC, Salmon C, et al. Human long-term bone marrow culture in serum-free medium. Exp Hematol 1988:16;abstract 367.
  33. Katsura Y. Redefinition of lymphoid progenitors. Nat. Rev. Immunol. 2002;2:1
  34. Van Rhee F, Hochaus A, Lin F, Melo JV, Goldman JM, Cross NCP. p190 BCR-ABL mRNA is expressed at low levels in p210-positive chronic myeloid and acute lymphoblastic leukemia. Blood. 1996;87:5213

PII: S0145-2126(02)00049-8

Leukemia Research
Volume 26, Issue 11 , Pages 997-1005 , November 2002

Article Tools

* Image Usage & Resolution